ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons
- PMID:19616072
- DOI: 10.1016/j.neulet.2009.07.032
ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons
Abstract
Apolipoprotein E (ApoE) 4 is a potent risk factor for Alzheimer's disease (AD). However, the mechanism underlying ApoE4 function in the pathology of AD is not well understood. We report here that, in comparison with ApoE2 and ApoE3, ApoE4 significantly reduces levels of insulin-degrading enzyme (IDE), which is responsible for the cellular clearance of Abeta in neurons. This differential regulation of IDE by various ApoE isoforms was blocked by coincubation with N-methyl-d-aspartic acid (NMDA) receptor inhibitors and receptor-associated protein (RAP), which blocked the interaction between ApoE and members of the low-density lipoprotein (LDL) receptor family. Moreover, inhibition of the NMDA receptor increased IDE levels in neurons, while activation of the NMDA receptor-reduced IDE expression. Further studies demonstrate that, as a pathway downstream of the NMDA receptor, cAMP-dependent protein kinase (PKA) contributes to the NMDA receptor-reduced IDE expression. These results suggest that ApoE4 down-regulates IDE expression in neurons by binding to its receptor and stimulating the NMDA receptor pathway, which may account for its role in AD pathogenesis.
Similar articles
- Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.Rapp A, Gmeiner B, Hüttinger M.Rapp A, et al.Biochimie. 2006 May;88(5):473-83. doi: 10.1016/j.biochi.2005.10.007. Epub 2005 Nov 15.Biochimie. 2006.PMID:16376010
- PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.Du J, Zhang L, Liu S, Zhang C, Huang X, Li J, Zhao N, Wang Z.Du J, et al.Biochem Biophys Res Commun. 2009 Jun 12;383(4):485-90. doi: 10.1016/j.bbrc.2009.04.047. Epub 2009 Apr 19.Biochem Biophys Res Commun. 2009.PMID:19383491
- Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.Song MS, Rauw G, Baker GB, Kar S.Song MS, et al.Eur J Neurosci. 2008 Nov;28(10):1989-2002. doi: 10.1111/j.1460-9568.2008.06498.x.Eur J Neurosci. 2008.PMID:19046381
- NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.Yamin G.Yamin G.J Neurosci Res. 2009 Jun;87(8):1729-36. doi: 10.1002/jnr.21998.J Neurosci Res. 2009.PMID:19170166Review.
- Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.Fan J, Donkin J, Wellington C.Fan J, et al.Biofactors. 2009 May-Jun;35(3):239-48. doi: 10.1002/biof.37.Biofactors. 2009.PMID:19472365Review.
Cited by
- Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.Asih PR, Tegg ML, Sohrabi H, Carruthers M, Gandy SE, Saad F, Verdile G, Ittner LM, Martins RN.Asih PR, et al.J Alzheimers Dis. 2017;59(2):445-466. doi: 10.3233/JAD-161259.J Alzheimers Dis. 2017.PMID:28655134Free PMC article.Review.
- Comprehensive evaluation of microRNA expression profiling reveals the neural signaling specific cytotoxicity of superparamagnetic iron oxide nanoparticles (SPIONs) through N-methyl-D-aspartate receptor.Sun B, Liu R, Ye N, Xiao ZD.Sun B, et al.PLoS One. 2015 Mar 23;10(3):e0121671. doi: 10.1371/journal.pone.0121671. eCollection 2015.PLoS One. 2015.PMID:25798908Free PMC article.
- Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume.Pedrini S, Doecke JD, Hone E, Wang P, Thota R, Bush AI, Rowe CC, Dore V, Villemagne VL, Ames D, Rainey-Smith S, Verdile G, Sohrabi HR, Raida MR, Taddei K, Gandy S, Masters CL, Chatterjee P, Martins RN; AIBL Research Group.Pedrini S, et al.J Neurochem. 2022 Oct;163(1):53-67. doi: 10.1111/jnc.15681. Epub 2022 Aug 24.J Neurochem. 2022.PMID:36000528Free PMC article.
- ApoE4: an emerging therapeutic target for Alzheimer's disease.Safieh M, Korczyn AD, Michaelson DM.Safieh M, et al.BMC Med. 2019 Mar 20;17(1):64. doi: 10.1186/s12916-019-1299-4.BMC Med. 2019.PMID:30890171Free PMC article.Review.
- Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.Dorey E, Chang N, Liu QY, Yang Z, Zhang W.Dorey E, et al.Neurosci Bull. 2014 Apr;30(2):317-30. doi: 10.1007/s12264-013-1422-z. Epub 2014 Mar 20.Neurosci Bull. 2014.PMID:24652457Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous